期刊文献+

类风湿性关节炎的临床治疗研究 被引量:35

Clinic Treating Discussion of Rheumatoid Arthrieis
下载PDF
导出
摘要 类风湿性关节炎(rheumatoid arthritis,RA)简称类风关,是以关节滑膜炎和关节外病变为主要临床表现的一种自身免疫性疾病。该病在中医属“痹证”范畴,认为其发病机制是因正虚感邪,风寒湿邪乘虚而入搏结于肌肉、筋骨,阻闭经络气血,留着关节筋骨,从而致关节肌肉酸楚疼痛、皮下结节、关节肿痛变形而成痹证。从现代医学与传统医学对RA的临床治疗入手,发现目前以中西医结合治疗效果最好;从传统医学的辨证分型入手,希望找到与现代医学的切合点。研究证明,早期发现、早期治疗、早期联合用药对治疗RA很关键;传统医学在辨证分型方面仍需要做大量工作。 The rheumatoid Arthritis (called RA for short) ,is a kind of autoimmune disease which chief clinical manifestation are arthrosynovitis and ex - arthrosis disese. When comes to traditional Chinese medicine, it belongs to the category of "arthromyodynia", and the pathogenesis is considered that the asthenia of healthy energy induce infecting evil, then, catching your opponent off- guard, the wind -cold - wetness evils are combined in muscles and bones, stop the me- ridian and the QI -blood and stay the arthrosis, bones and muscles, accordingly, it result that the arthrosis and muscles sour and pain, subcutaneous nodule, and arthrosis swelling and pain, deformation, eventually, it result in the arthromyodynia. Considering about the clinic treat of the RA from the modern medicine and the TCM,we think the therapeutic efficacy of the combined treatment of traditional Chinese medicine and Western medicine is the best. From the dialectical typing of the traditional Chinese medicine, we hope to find the combining site to the modern medicine. The study demonstrated that, the early discovery, early treatment and early drug combination are very important to RA therapy ; it still have a lot work to do in the dialectical typing of the traditional Chinese medicine.
作者 李瑞 孟庆刚
机构地区 北京中医药大学
出处 《中华中医药学刊》 CAS 2007年第7期1348-1352,共5页 Chinese Archives of Traditional Chinese Medicine
基金 科技部基础性工作专项课题(2001DEA2001O) 教育部博士点基金项目(20050026011)
关键词 类风湿性关节炎 治疗 辨证分型 rheumatoid arthritis therapy dialectical typing
  • 相关文献

参考文献15

二级参考文献51

  • 1王绪辉,周重建,闵熙敬,朱显华,沈培芝,项琼,魏森苗,王思辉.防己黄芪汤提取物治疗活动期类风湿性关节炎的临床药效评估[J].中医杂志,1993,34(3):156-158. 被引量:24
  • 2Saay K, Koehnke R,Caldwell 3, et al. Low-dose Long-term Corticosteroid Therapy in Rheumatoid Arthritis:an Analysis of Serious Adverse Effects[J]. AM 3 med, 1994, (96): 115.
  • 3Stancikova M, Stancik R, Gubzova Z,et al. Collagen in the treatment of rheumatic diseases-oral tolerance[J]. Bratisl Lek Listy, 1999, 100(10) : 567.
  • 4Willis D, Moore AR, Gowland G, et al. OM-89 modulation of chronic inflammation: relevance to clinical use[J]. Br J Rheumatol, 1995, 34(6): 525.
  • 5New patent for manufacture of Anergen's AnergiX pharmaceutical compounds [ Drug News ] [ C ]. Investigational Drugs daily highlights, 1998,4(8): 10.
  • 6]Anergen's RA vaccine safe and well-tolerated in phase Ⅱ tri als [Drug News] [C]. Investigational Drugs daily highlights, 1997,11(11): 12.
  • 7Initiation of IR-501 rheumatoid arthritis clinical trial [Drug News][C]. Investigational Drugs daily highlights, 1998,19(8):14.
  • 8Sharma A,Davis CB,Tobia LA, et al. Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4[J]. J Pharmacol Exp Ther, 2000, 293(1):33.
  • 9Martin J, Glennie and Peter W M Johnson. Clinical trials of antibody therapy[J]. Immunology Today, 2000, 21(8):403.?A?A?A
  • 10Salomon B, Bluestone J A. Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation[J]. Annual Review of Immunology, 2001, 19(4) :225.

共引文献262

同被引文献410

引证文献35

二级引证文献422

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部